Skip to main content
. 2023 Aug 12;12(16):5261. doi: 10.3390/jcm12165261
BBB Blood–brain barrier
CAR Chimeric antigen receptor
CTX Chemotherapy
DFMO Difluoromethylornithine
DIPG Diffuse intrinsic pontine glioma
DMG Diffuse midline glioma
FDA Food and Drug Administration
GD2 Disialoganglioside-2
H3 Histone 3
NOS Not otherwise specified
OS Overall survival
PFS Progression-free survival
QoL Quality of life
RT Radiotherapy
TILs Tumor-infiltrating lymphocytes
WHO World Health Organization